NCT02819011 2020-02-27
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Baylor College of Medicine
Phase 2 Completed
Baylor College of Medicine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
National Institutes of Health Clinical Center (CC)